In preclinical models of polymicrobial sepsis, such as the cecal slurry and cecal ligation puncture (CLP) models, long-acting GLP-1 receptor agonists (GLP-1RAs) like semaglutide have demonstrated protective effects
Nielsen J, Friedman S, Norgard BM, Knudsen T, Kjeldsen J, Wod M
With improved blood sugar control, individuals experience fewer diabetes-related symptoms and complications, leading to a better overall quality of life
[DOI] [PMC free article] [PubMed] [Google Scholar] 32.Nakatani Y, Maeda M, Matsumura M, et al
Yes, GLP-1 medications commonly cause changes in bowel movements, though the nature and severity of these changes vary significantly among patients
Clinical trials consistently demonstrate that patients using Ozempic achieve greater weight loss outcomes compared to those relying solely on lifestyle modifications or other weight-loss medications